AnnotSV_ID	SV_chrom	SV_start	SV_end	SV_length	sample	SV_type	rendu	note	Annotation_mode	Gene_name	Gene_count	Tx	Tx_start	Tx_end	Overlapped_tx_length	Overlapped_CDS_length	Overlapped_CDS_percent	Frameshift	Exon_count	Location	Location2	Dist_Nearest_SS	Nearest_SS_type	Intersect_Start	Intersect_End	RE_gene	B_gain_source	B_gain_coord	B_loss_source	B_loss_coord	B_ins_source	B_ins_coord	B_inv_source	B_inv_coord	P_gain_phen	P_gain_hpo	P_gain_source	P_gain_coord	P_loss_phen	P_loss_hpo	P_loss_source	P_loss_coord	P_ins_phen	P_ins_hpo	P_ins_source	P_ins_coord	P_snvindel_nb	P_snvindel_phen	TAD_coordinate	ENCODE_experiment	Cosmic_ID	Cosmic_mut_typ	GC_content_left	GC_content_right	Repeat_coord_left	Repeat_type_left	Repeat_coord_right	Repeat_type_right	Gap_left	Gap_right	SegDup_left	SegDup_right	ENCODE_blacklist_left	ENCODE_blacklist_characteristics_left	ENCODE_blacklist_right	ENCODE_blacklist_characteristics_right	ACMG	HI	TS	DDD_HI_percent	DDD_status	DDD_mode	DDD_consequence	DDD_disease	DDD_pmid	ExAC_delZ	ExAC_dupZ	ExAC_cnvZ	ExAC_synZ	ExAC_misZ	OMIM_ID	OMIM_phenotype	OMIM_inheritance	OMIM_morbid	OMIM_morbid_candidates	LOEUF_bin	GnomAD_pLI	ExAC_pLI	AnnotSV_ranking_score	AnnotSV_ranking_criteria	ACMG_class
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	full	ARHGAP15;GTDC1;KYNU;LINC01412;LOC101928386;LOC105373656;LRP1B;PABPC1P2;TEX41;ZEB2;ZEB2-AS1	11															ACVR2A;MBD5 (HI=3;TS=1);ORC4 (HI=30;TS=0)							IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685	Mowat-Wilson_syndrome		CLN:448705	2:145156601-145156716	?Hydroxykynureninuria, 236800 (3);Catel_Manzke_syndrome;Mowat-Wilson syndrome, 235730 (3);Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)		CLN:966395;HI3:ZEB2;morbid:KYNU;morbid:ZEB2	2:143634576-143719262;2:143635232-143813402;2:145141942-145277958;2:145268951-145277686					135	Catel_Manzke_syndrome;Congenital_NAD_deficiency_disorder;History_of_neurodevelopmental_disorder;Inborn_genetic_diseases;Intellectual_disability;Mowat-Wilson_syndrome;Smith-Magenis_Syndrome-like;VERTEBRAL,_CARDIAC,_RENAL,_AND_LIMB_DEFECTS_SYNDROME_2	2:142280001-142920000;2:142280001-143000000;2:142320001-142880000;2:142320001-142920000;2:142320001-143800000;2:142320001-143960000;2:142360001-142840000;2:142400001-142840000;2:142400001-143920000;2:142720001-143480000;2:142800001-143480000;2:142800001-143880000;2:142800001-143920000;2:142800001-144040000;2:142840001-143440000;2:142840001-143520000;2:142840001-143880000;2:142840001-143920000;2:142880001-143400000;2:142880001-143800000;2:142880001-143880000	ENCFF032FMN:ENCFF066NYU:ENCFF075QYD:ENCFF136AUY:ENCFF248DGB:ENCFF274VJU:ENCFF306YQN:ENCFF310FEU:ENCFF336WPU:ENCFF373MCF:ENCFF437EBV:ENCFF444XGA:ENCFF451MCF:ENCFF471EYL:ENCFF477VVJ:ENCFF531PAV:ENCFF558RGV:ENCFF569KNS:ENCFF588KUZ:ENCFF633ORE:ENCFF654GDV	1000076;1003907;1003911;1006180;1006181;1006467;1006474;101097;1012696;1013462;1020483;1020998;1029264;1029266;1029267;1032637;1032639;1032640;1032641;1032643;1032644;1032645;1036630;1044356;1047968;1047969;1073735;1082032;109042;10945;1099203;1099717;110324;110325;111342;1124560;1135301;115053;1161192;116236;1171252;118870;1204257;12064;120719;120720;122815;122816;124032;124677;1257695;...	gain;loss	0.320	0.340																																			1.0	1A;2A (cf P_loss_source);3A (11 genes)	5
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	ARHGAP15		NM_018460	143886987	144525921	638934	1428	100	no	14	txStart-txEnd	5'UTR-3'UTR			143886987	144525921								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																	1032637;1032639;209667;2488897;249508;273280;3068491;3417;425197;432943;479660;498346;498347;507287;527716;536699;559737;570577;587459;597631;707670;722104;722105;722106;722107;722108;722109;722110;734964;741656;741657;765190;765191;765192;765193;765195;765196;785064;808718;812096;851945;860038;865641;966434;966435;966436;976600;982013;988312;999119	gain;loss																		0.39						0.0693083894648098	-0.313560681801348	-0.162050293981424	-0.414674347136382	-0.314567510411296						4	1.3720e-08	5.2541e-06		
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	GTDC1		NM_001376306	144695636	145090079	394443	1524	100	no	13	txStart-txEnd	5'UTR-3'UTR			144695636	145090079								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																	1032641;1032643;1032644;1032645;1047969;1099717;2032908;2364996;273283;59356;694749;707672;707673;707674;707675;707676;707677;707678;707679;722120;722121;722122;722123;722124;722125;722126;765197	gain;loss																		2.92						-1.32758543319309	0.276107196209042	-0.411459590620902	0.90437703811114	-1.23824868015629						7	1.0127e-12	2.4090e-10		
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	KYNU		NM_001199241	143635232	143813402	178170	1398	100	no	15	txStart-txEnd	5'UTR-3'UTR			143635232	143813402								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685					?Hydroxykynureninuria, 236800 (3);Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)		morbid:KYNU	2:143635232-143813402					6	Catel_Manzke_syndrome;Congenital_NAD_deficiency_disorder;VERTEBRAL,_CARDIAC,_RENAL,_AND_LIMB_DEFECTS_SYNDROME_2			50451;707663;707664;707665;707666;741651;741652;851943	gain;loss																		41.86						0.00626463044787885	0.495546633769546	0.378525104033653	-0.493020841165644	-1.14319607793643	605197	Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)/ ?Hydroxykynureninuria, 236800 (3)	AR	yes	yes	7	4.1806e-18	1.8277e-09		
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	LINC01412		NR_110570	145279434	145337001	57567	0	0	no	3	txStart-txEnd	UTR			145279434	145337001								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																																																								
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	LOC101928386		NR_110237	144694633	144721722	27089	0	0	no	3	txStart-txEnd	UTR			144694633	144721722								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																	59356	gain																																						
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	LOC105373656		NR_136320	145281116	145282011	895	0	0	no	2	txStart-txEnd	UTR			145281116	145282011								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																																																								
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	LRP1B		NM_018557	140988991	142888585	672217	343	2	yes	91	txStart-intron3	5'UTR-CDS	21596	5'	142216368	142888585								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685																	1006180;1006181;1006467;1006474;1073735;1082032;1124560;1135301;1161192;116236;1171252;1204257;1357371;1518025;1527713;153330;1574009;1597095;1635998;1725277;1725820;173253;1875681;1889122;1912772;196213;1963487;209660;209661;209662;209664;211670;211671;211672;2211391;2272725;2289520;2293288;2328718;2359186;2425910;2482595;252493;2577026;2577027;273267;273268;273270;273272;273273;2755167;...	gain;loss																		1.62						-0.672226653195572	0.849209882795508	0.329622238840903	-1.57118316036647	0.672316636355286						1	2.5267e-06	1.0000e+00		
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	PABPC1P2		NR_026904	147344624	147348558	3934	0	0	no	1	txStart-txEnd	UTR			147344624	147348558								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																																																								
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	TEX41		NR_033870	145425533	145834291	408758	0	0	no	5	txStart-txEnd	UTR			145425533	145834291								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																																																								
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	ZEB2		NM_014795	145141647	145277686	136039	3645	100	no	10	txStart-txEnd	5'UTR-3'UTR			145141647	145277686								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541	Mowat-Wilson_syndrome		CLN:448705	2:145156601-145156716	Mowat-Wilson syndrome, 235730 (3)		morbid:ZEB2	2:145268951-145277686					129	History_of_neurodevelopmental_disorder;Inborn_genetic_diseases;Intellectual_disability;Mowat-Wilson_syndrome;Smith-Magenis_Syndrome-like			1257695;273285;507289;707681;741660	gain;loss																3	0	0.37	confirmed	monoallelic	loss of function	MOWAT-WILSON SYNDROME	9719364;16532472;16688751;11279515;11891681;12920073;12451214;11592033;16088920;11595972	-0.949172238522553	-0.414940535299876	-0.631528877179671	1.20087572946893	4.94560342770108	605802	Mowat-Wilson syndrome, 235730 (3)	AD	yes		0	1.0000e+00	9.9983e-01		
2_142216368_148540744_DEL_1	2	142216368	148540744	-6324376	CSG182557	DEL	Pathogène	5	split	ZEB2-AS1		NR_040248	145277180	145278465	1285	0	0	no	4	txStart-txEnd	UTR			145277180	145278465								IMH	2:26280500-162970618;2:122235797-235423496;2:137647843-222431685;2:143803781-206683541																																																								
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	full	C4orf48;FAM53A;FGFR3;LETM1;MIR943;NAT8L;NELFA;NSD2;POLN;SCARNA22;SLBP;TACC3;TMEM129	13															CTBP1;CTBP1-DT;FAM193A;FGFRL1 (HI=0;TS=0);GAK;HAUS3;IDUA;MAEA;MFSD10;MXD4;NKX1-1;NOP14-AS1;PDE6B;RNF212;RNF4;SH3BP2;TMEM175;UVSSA;ZFYVE28													?N-acetylaspartate deficiency, 614063 (3);Achondroplasia, 100800 (3);Bladder cancer, somatic, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 114500 (3);Crouzon syndrome with acanthosis nigricans, 612247 (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Nevus, epidermal, somatic, 162900 (3);SADDAN, 616482 (3);Spermatocytic seminoma, somatic, 273300 (3);Thanatophoric dysplasia, type I, 187600 (3);Thanatophoric dysplasia, type II, 187601 (3)		morbid:FGFR3;morbid:NAT8L	4:1795038-1810599;4:2061053-2070816					31	4p_partial_monosomy_syndrome;Absence_seizures;Achondroplasia;Bell-shaped_thorax;Birth_length_less_than_3rd_percentile;Bladder_carcinoma;Bowed_humerus;Bowing_of_the_long_bones;Camptodactyly-tall_stature-scoliosis-hearing_loss_syndrome;Carcinoma;Carcinoma_of_cervix;Carcinoma_of_colon;Cloverleaf_skull;Coronal_craniosynostosis;Craniosynostosis;Crouzon_syndrome;Crouzon_syndrome_with_acanthosis_nigricans;Disproportionate_short-limb_short_stature;Epidermal_nevus;FGFR3-related_disorder;Facial_asymmetry;Femoral_bowing;Growth_delay;Hypochondroplasia;Inborn_genetic_diseases;Infantile_axial_hypotonia;Lethal_short-limbed_short_stature;Lethal_skeletal_dysplasia;Levy-Hollister_syndrome;Lower_limb_undergrowth;Lung_adenocarcinoma;Macrocephalus;Malignant_tumor_of_testis;Muenke_syndrome;Multiple_myeloma;Narrow_chest;Papillary_renal_cell_carcinoma,_sporadic;Platyspondyly;Polyhydramnios;Saethre-Chotzen_syndrome;Seborrheic_keratosis;Seizures;Severe_achondroplasia_with_developmental_delay_and_acanthosis_nigricans;Short_long_bone;Short_ribs;Short_stature;Skeletal_dysplasia;Skeletal_dysplasia_with_acanthosis_nigricans;Small_for_gestational_age;Spermatocytic_seminoma;Squamous_cell_carcinoma_of_the_head_and_neck;Squamous_cell_lung_carcinoma;Thanatophoric_dysplasia,_type_2;Thanatophoric_dysplasia_type_1;Transitional_cell_carcinoma_of_the_bladder;Unilateral_renal_agenesis;Upper_limb_undergrowth;Urinary_bladder_cancer;Wolf-Hirschhorn_like_syndrome;not_specified	4:1720001-3040000;4:1720001-3160000;4:1760001-3040000;4:1760001-3080000;4:1760001-3120000;4:1760001-3160000;4:1800001-2960000;4:1800001-3120000;4:1840001-3080000;4:1840001-3120000;4:1880001-3040000;4:1880001-3080000;4:1880001-4240000;4:1920001-3080000	ENCFF032FMN:ENCFF066NYU:ENCFF075QYD:ENCFF136AUY:ENCFF248DGB:ENCFF274VJU:ENCFF306YQN:ENCFF310FEU:ENCFF336WPU:ENCFF373MCF:ENCFF437EBV:ENCFF444XGA:ENCFF451MCF:ENCFF471EYL:ENCFF477VVJ:ENCFF531PAV:ENCFF558RGV:ENCFF569KNS:ENCFF588KUZ:ENCFF633ORE:ENCFF654GDV	1001499;1004750;1004754;1004779;1007663;1011043;1025984;1025985;1058379;1062967;11195;112484;112877;112880;112888;12231;1243661;12484;1295174;1421133;1727997;1861340;19428;19431;1966341;208376;2090468;2115035;2218492;22811;23013;240662;241002;24404;249596;249761;26076;26084;26093;264050;264065;264093;27625;276733;276739;276798;27767;2883845;289086;290678;292280;...	gain;loss	0.535	0.380																																			0.0	1A;3A (13 genes)	3
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	C4orf48		NM_001168243	2043719	2045697	1978	387	100	no	4	txStart-txEnd	5'UTR-3'UTR			2043719	2045697																																													80.21																7	5.1423e-01			
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	FAM53A		NM_001174070	1641607	1686040	44433	1197	100	no	5	txStart-txEnd	5'UTR-3'UTR			1641607	1686040																										336174;336489	loss																		86.49									-0.576730190868019	-0.56780381579822						6	3.5705e-03	3.0070e-05		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	FGFR3		NM_001163213	1795038	1810599	15561	2427	100	no	18	txStart-txEnd	5'UTR-3'UTR			1795038	1810599														Achondroplasia, 100800 (3);Bladder cancer, somatic, 109800 (3);CATSHL syndrome, 610474 (3);Cervical cancer, somatic, 603956 (3);Colorectal cancer, somatic, 114500 (3);Crouzon syndrome with acanthosis nigricans, 612247 (3);Hypochondroplasia, 146000 (3);LADD syndrome, 149730 (3);Muenke syndrome, 602849 (3);Nevus, epidermal, somatic, 162900 (3);SADDAN, 616482 (3);Spermatocytic seminoma, somatic, 273300 (3);Thanatophoric dysplasia, type I, 187600 (3);Thanatophoric dysplasia, type II, 187601 (3)		morbid:FGFR3	4:1795038-1810599					22	Absence_seizures;Achondroplasia;Bell-shaped_thorax;Birth_length_less_than_3rd_percentile;Bladder_carcinoma;Bowed_humerus;Bowing_of_the_long_bones;Camptodactyly-tall_stature-scoliosis-hearing_loss_syndrome;Carcinoma;Carcinoma_of_cervix;Carcinoma_of_colon;Cloverleaf_skull;Coronal_craniosynostosis;Craniosynostosis;Crouzon_syndrome;Crouzon_syndrome_with_acanthosis_nigricans;Disproportionate_short-limb_short_stature;Epidermal_nevus;FGFR3-related_disorder;Facial_asymmetry;Femoral_bowing;Growth_delay;Hypochondroplasia;Inborn_genetic_diseases;Infantile_axial_hypotonia;Lethal_short-limbed_short_stature;Lethal_skeletal_dysplasia;Levy-Hollister_syndrome;Lower_limb_undergrowth;Lung_adenocarcinoma;Macrocephalus;Malignant_tumor_of_testis;Muenke_syndrome;Multiple_myeloma;Narrow_chest;Papillary_renal_cell_carcinoma,_sporadic;Platyspondyly;Polyhydramnios;Saethre-Chotzen_syndrome;Seborrheic_keratosis;Seizures;Severe_achondroplasia_with_developmental_delay_and_acanthosis_nigricans;Short_long_bone;Short_ribs;Short_stature;Skeletal_dysplasia;Skeletal_dysplasia_with_acanthosis_nigricans;Small_for_gestational_age;Spermatocytic_seminoma;Squamous_cell_carcinoma_of_the_head_and_neck;Squamous_cell_lung_carcinoma;Thanatophoric_dysplasia,_type_2;Thanatophoric_dysplasia_type_1;Transitional_cell_carcinoma_of_the_bladder;Unilateral_renal_agenesis;Upper_limb_undergrowth;Urinary_bladder_cancer;not_specified			393816;393817;395197	loss																0	0	6.4	confirmed/confirmed/confirmed/confirmed/confirmed/confirmed/confirmed/confirmed	monoallelic/monoallelic/monoallelic/monoallelic/monoallelic/monoallelic/monoallelic/monoallelic	all missense/in frame/activating/activating/activating/activating/all missense/in frame/activating/activating	LACRIMO-AURICULO-DENTO-DIGITAL SYNDROME/MUENKE SYNDROME/CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS/ACHONDROPLASIA/THANATOPHORIC DYSPLASIA TYPE 2/CAMPTODACTYLY TALL STATURE AND HEARING LOSS SYNDROME/HYPOCHONDROPLASIA/THANATOPHORIC DYSPLASIA TYPE 1	16501574;28483234//7493034/16411219;8078586;7758520;16912704;7913883/7773297/27139183;17033969/11055896;7670477;16912704;10215410;9452043;8589686/19449430;7647778;7773297;8845844	-0.683349552436101	-0.392116289350703	-0.538573860699497	-2.22163439002498	1.36559781959522	134934	Muenke syndrome, 602849 (3)/ Nevus, epidermal, somatic, 162900 (3)/ Thanatophoric dysplasia, type II, 187601 (3)/ Bladder cancer, somatic, 109800 (3)/ CATSHL syndrome, 610474 (3)/ Crouzon syndrome with acanthosis nigricans, 612247 (3)/ Hypochondroplasia, 146000 (3)/ LADD syndrome, 149730 (3)/ Achondroplasia, 100800 (3)/ Thanatophoric dysplasia, type I, 187600 (3)/ Colorectal cancer, somatic, 114500 (3)/ Spermatocytic seminoma, somatic, 273300 (3)/ Cervical cancer, somatic, 603956 (3)/ SADDAN, 616482 (3)	AD//AD//AR, AD/AD/AD/AD/AD/AD////AD	yes		3	1.6432e-05	2.9091e-03		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	LETM1		NM_012318	1813205	1857883	44678	2220	100	no	14	txStart-txEnd	5'UTR-3'UTR			1813205	1857883																																											0	0	63.78						0.214548231055587	-0.175454101774909	-0.0279109913872425	-1.46983950545222	1.90036967420169						3	1.2141e-06	8.1055e-02		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	MIR943		NR_030641	1988110	1988204	94	0	0	no	1	txStart-txEnd	UTR			1988110	1988204																																																																	
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	NAT8L		NM_178557	2061053	2070816	9763	909	100	no	3	txStart-txEnd	5'UTR-3'UTR			2061053	2070816		gnomAD-SV_v2.1_DUP_4_10952	4:2060724-2076000											?N-acetylaspartate deficiency, 614063 (3)		morbid:NAT8L	4:2061053-2070816																										30	0	40.87						0.098456637925367	0.547035422647778	0.555421231184509	-0.17378562567541	2.72200675038499	610647	?N-acetylaspartate deficiency, 614063 (3)	AR		yes	2	8.6458e-01	3.2468e-01		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	NELFA		NM_005663	1984450	2010701	26251	1587	100	no	11	txStart-txEnd	5'UTR-3'UTR			1984450	2010701																										430475	gain																0	0	62.86						0.0789021097033232	0.586448065563417	0.486612084123194	-0.704500724266535	2.35326609523799						2	1.3469e-01	1.6689e-01		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	NSD2		NM_001042424	1873119	1983919	110800	4098	100	no	22	txStart-txEnd	5'UTR-3'UTR			1873119	1983919																						9	4p_partial_monosomy_syndrome;Inborn_genetic_diseases;Wolf-Hirschhorn_like_syndrome			264093;393850;393851;395144;395188;621015;743764;743765;743766;743767	gain;loss																			probable	monoallelic	loss of function	NSD2-related developmental disorder (monoallelic)																
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	POLN		NM_181808	2073644	2243848	84769	972	35	no	26	intron16-txEnd	CDS-3'UTR	101	5'	2073644	2158413																																													74.11						1.28008098953073	-0.213680271829885	0.298427608261686	0.0230368692484615	-1.08931776314455						7	9.4880e-41	2.9966e-32		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	SCARNA22		NR_003004	1976362	1976487	125	0	0	no	1	txStart-txEnd	UTR			1976362	1976487																																																																	
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	SLBP		NM_006527	1694457	1714046	19589	813	100	no	8	txStart-txEnd	5'UTR-3'UTR			1694457	1714046																																													41.08						-0.996144409589105	-0.44060461568473	-0.660904930034766	-0.443208130978936	0.50373477013136						4	6.8148e-02	5.1566e-01		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	TACC3		NM_006342	1723247	1746897	23650	2517	100	no	16	txStart-txEnd	5'UTR-3'UTR			1723247	1746897																										595624	gain																		92.5						-0.738565549612952	-1.04002887445022	-0.98783763752124	-1.00228696058413	-1.35276544118498						3	2.7082e-07	9.1952e-02		
4_1563818_2158413_DUP_1	4	1563818	2158413	594595	CLA190062	DUP	VOUS	3	split	TMEM129		NM_001127266	1717678	1723050	5372	1089	100	no	4	txStart-txEnd	5'UTR-3'UTR			1717678	1723050																																													60.14									1.8774465029651	0.292414150336672						8	2.3074e-11	1.5746e-06		
7_110276505_110478039_DEL_1	7	110276505	110478039	-201534	CSG170046	DEL	VOUS	3	full	IMMP2L	1															LRRN3							IMH	7:66631328-143298938;7:94121576-144414055															7:110400001-111360000	ENCFF274VJU:ENCFF588KUZ	1021405;1021406;1206753;1361904;1422259;1445141;1447114;1537272;1622263;1704034;2039835;2091718;2210159;2288763;2622125;2758442;2856955;2894686;484312;493395;493396;493397;493659;538177;663142;665138;667593;669389;669390;673827;674366;677180;683755;691734;699472;728411;728412;775675;775676;825184	gain;loss	0.350	0.360	7:110276590-110276648	L2b														4.25						-2.62354415217069	0.194113758998799	-2.47162789907313	-0.54322591056105	-0.0234666178325726							1.1165e-02	4.0761e-02	0.0	1A;3A (1 gene)	3
7_110276505_110478039_DEL_1	7	110276505	110478039	-201534	CSG170046	DEL	VOUS	3	split	IMMP2L		NM_001244606	110302699	111202548	175340	120	22	no	7	intron6-txEnd	CDS-3'UTR	48609	5'	110302699	110478039								IMH	7:66631328-143298938;7:94121576-144414055																	1021405;1021406;1206753;1361904;1422259;1445141;1447114;1537272;1622263;1704034;2039835;2091718;2210159;2288763;2622125;2758442;2856955;2894686;484312;493395;493396;493397;493659;538177;663142;665138;667593;669389;669390;673827;674366;677180;683755;691734;699472;728411;728412;775675;775676;825184	gain;loss																		4.25						-2.62354415217069	0.194113758998799	-2.47162789907313	-0.54322591056105	-0.0234666178325726						6	1.1165e-02	4.0761e-02		
11_5247723_5273846_DEL_1	11	5247723	5273846	-26123	CSG181869	DEL	Pathogène	4	full	BGLT3;HBB;HBBP1;HBD;HBG1	5															HBG2;OR51B2;OR51B4;OR51B5;OR51B6;OR51I1;OR51I2;OR51J1;OR51M1;OR51Q1;OR51V1;OR52A1;TRIM68							IMH	11:1642919-71249653					Fetal hemoglobin quantitative trait locus 1, 141749 (3);Thalassemia due to Hb Lepore (3);Thalassemia, delta- (3);beta_Thalassemia		CLN:581827;morbid:HBD;morbid:HBG1	11:5248134-5248427;11:5254067-5255713;11:5269498-5271087					98	Abnormality_of_the_hand;Anemia;Beta-knossos-thalassemia;Beta-malay-thalassemia;Beta-plus-thalassemia;Beta-thalassemia,_dominant_inclusion_body_type;Beta-thalassemia,_lermontov_type;Beta_thalassemia_intermedia;Beta_thalassemia_major;Erythrocytosis_6,_familial;Fetal_hemoglobin_quantitative_trait_locus_1;HBB-Related_Disorders;HEMOGLOBIN_C;HEMOGLOBIN_CHIBA;HEMOGLOBIN_HAMMERSMITH;HEMOGLOBIN_KNOSSOS;HEMOGLOBIN_MALAY;HEMOGLOBIN_M_(RADOM)_METHEMOGLOBINEMIA,_BETA_TYPE;HEMOGLOBIN_M_(SASKATOON);HEMOGLOBIN_OLYMPIA;HEMOGLOBIN_SABINE;HEMOGLOBIN_SANTA_ANA;HEMOGLOBIN_VILA_REAL;Hb_SS_disease;Heinz_body_anemia;Hemoglobin_E;Hemoglobin_E/beta_thalassemia_disease;Hemoglobin_E_disease;Hemoglobinopathy;Hypoplasia_of_the_ulna;Inborn_genetic_diseases;Malaria,_resistance_to;Methemoglobinemia,_beta-globin_type;Microcytic_anemia;Splenomegaly;Susceptibility_to_malaria;Thoracic_scoliosis;alpha_Thalassemia;beta^0^_Thalassemia;beta_Thalassemia;not_specified			453101	loss	0.390	0.415	11:5247587-5247663	A-rich						11:5272859-5277141																											1.0	1A;2A (cf P_loss_source);3A (5 genes)	5
11_5247723_5273846_DEL_1	11	5247723	5273846	-26123	CSG181869	DEL	Pathogène	4	split	BGLT3		NR_121648	5265783	5266776	993	0	0	no	1	txStart-txEnd	UTR			5265783	5266776								IMH	11:1642919-71249653																																																								
11_5247723_5273846_DEL_1	11	5247723	5273846	-26123	CSG181869	DEL	Pathogène	4	split	HBB		NM_000518	5246693	5248301	578	315	70	no	3	txStart-intron2	5'UTR-CDS	83	5'	5247723	5248301								IMH	11:1642919-71249653													82	Abnormality_of_the_hand;Anemia;Beta-knossos-thalassemia;Beta-malay-thalassemia;Beta-plus-thalassemia;Beta-thalassemia,_dominant_inclusion_body_type;Beta-thalassemia,_lermontov_type;Beta_thalassemia_major;Erythrocytosis_6,_familial;Fetal_hemoglobin_quantitative_trait_locus_1;HBB-Related_Disorders;HEMOGLOBIN_C;HEMOGLOBIN_CHIBA;HEMOGLOBIN_HAMMERSMITH;HEMOGLOBIN_KNOSSOS;HEMOGLOBIN_MALAY;HEMOGLOBIN_M_(RADOM)_METHEMOGLOBINEMIA,_BETA_TYPE;HEMOGLOBIN_M_(SASKATOON);HEMOGLOBIN_OLYMPIA;HEMOGLOBIN_SABINE;HEMOGLOBIN_SANTA_ANA;HEMOGLOBIN_VILA_REAL;Hb_SS_disease;Heinz_body_anemia;Hemoglobin_E;Hemoglobin_E/beta_thalassemia_disease;Hemoglobin_E_disease;Hemoglobinopathy;Hypoplasia_of_the_ulna;Inborn_genetic_diseases;Malaria,_resistance_to;Methemoglobinemia,_beta-globin_type;Microcytic_anemia;Splenomegaly;Susceptibility_to_malaria;Thoracic_scoliosis;alpha_Thalassemia;beta^0^_Thalassemia;beta_Thalassemia;not_specified																						57.13						-2.62354415217069	-2.53125239294469	-2.47162789907313	-1.96331260869213	-0.568017270792556	141900	Thalassemia, beta, 613985 (3)/ Erythrocytosis 6, 617980 (3)/ Heinz body anemia, 140700 (3)/ Delta-beta thalassemia, 141749 (3)/ Thalassemia-beta, dominant inclusion-body, 603902 (3)/ Hereditary persistence of fetal hemoglobin, 141749 (3)/ Methemoglobinemia, beta type, 617971 (3)/ (Malaria, resistance to), 611162 (3)/ Sickle cell anemia, 603903 (3)	//AD/AD//AD///AR	yes	yes	9	1.2274e-09	1.0249e-08		
11_5247723_5273846_DEL_1	11	5247723	5273846	-26123	CSG181869	DEL	Pathogène	4	split	HBBP1		NR_001589	5263184	5264822	1638	0	0	no	3	txStart-txEnd	UTR			5263184	5264822								IMH	11:1642919-71249653																																																								
11_5247723_5273846_DEL_1	11	5247723	5273846	-26123	CSG181869	DEL	Pathogène	4	split	HBD		NM_000519	5254067	5255713	1646	444	100	no	3	txStart-txEnd	5'UTR-3'UTR			5254067	5255713								IMH	11:1642919-71249653					Thalassemia due to Hb Lepore (3);Thalassemia, delta- (3)		morbid:HBD	11:5254067-5255713																												77.18									-0.203398233874436	-1.15614462192474	142000	Thalassemia, delta- (3)/ Thalassemia due to Hb Lepore (3)		yes		9	1.9236e-05	1.5511e-04		
11_5247723_5273846_DEL_1	11	5247723	5273846	-26123	CSG181869	DEL	Pathogène	4	split	HBG1		NM_000559	5269498	5271087	1589	444	100	no	3	txStart-txEnd	5'UTR-3'UTR			5269498	5271087								IMH	11:1642919-71249653					Fetal hemoglobin quantitative trait locus 1, 141749 (3)		morbid:HBG1	11:5269498-5271087																												86.01									1.6907442803648	1.62238135952892	142200	Fetal hemoglobin quantitative trait locus 1, 141749 (3)	AD	yes		6	5.6611e-01	2.9779e-02		
